Aimei Health Technology Co., Ltd Ordinary Share

10-Year Study

AFJK.US · Financial Services · US · Common Stock

Executive Summary: Aimei Health Technology Co., Ltd Ordinary Share has compounded at 99.4% annually over the last 10 years, with a maximum drawdown of 61.7% and an annualized volatility of 659.1%.

1Y CAGR
+391.9%
3Y CAGR
+99.4%
5Y CAGR
+99.4%
10Y CAGR
+99.4%

History & Riski10-year historical performance analysis including CAGR, Max Drawdown, Sharpe & Sortino ratios, annual returns, and rolling volatility — all computed from daily market data.

10-Year Growth of $10,000

Max DrawdownMax DrawdownThe largest peak-to-trough decline in the asset's value over the measurement period.Click for full definition →
61.7%
Sharpe RatioSharpe RatioRisk-adjusted return: how much excess return you earn per unit of total risk (volatility).Click for full definition →
2.13
Sortino RatioSortino RatioLike Sharpe, but only penalizes downside volatility — a more accurate risk measure for asymmetric return distributions.Click for full definition →
14.00
Ann. VolatilityAnnualized VolatilityThe annualized standard deviation of an asset's returns — a measure of how much prices fluctuate.Click for full definition →
341.5%
Best YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2025 · +498.2%
Worst YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2026 · -25.0%
% Positive Years% Positive YearsThe percentage of calendar years in the measurement period where the asset delivered a positive return.Click for full definition →
50%

Annual Returns

Rolling 12-Month Returns

Rolling 12-Month Annualised Volatility

Historical Drawdowns

Monthly Returns

Monthly Returns Heatmap

YearJanFebMarAprMayJunJulAugSepOctNovDecAnn.
2026-17.8-38.6-24.295.9————————-25.0%
20250.51.90.40.31.00.11.30.00.21.1-6.9501.0498.2%
2024—-0.31.00.00.60.30.40.50.41.00.30.85.1%

Risk X-RayiA 19-factor macroeconomic risk decomposition showing exactly which market forces (equity beta, rates, inflation, credit, commodity, crypto) drive this asset's volatility. Powered by multivariate regression against daily factor returns.

Risk Profile Insight: This asset has an estimated annualized volatility of 659.1%. The dominant macroeconomic risk driver is SHV.US, accounting for 88.2% of variance. Idiosyncratic stock-specific factors contribute 2.0%.

10-Year Historical Price Series (Growth of $10,000)
DateSimulated Value
2024-01-0110000
2024-02-019974.459724950884
2024-03-0110078.585461689587
2024-04-0110078.585461689587
2024-05-0110137.524557956778
2024-06-0110166.994106090373
2024-07-0110206.286836935167
2024-08-0110255.402750491157
2024-09-0110294.695481335953
2024-10-0110392.927308447937
2024-11-0110422.396856581532
2024-12-0110510.805500982318
2025-01-0110559.921414538312
2025-02-0110756.385068762278
2025-03-0110802.554027504912
2025-04-0110834.970530451867
2025-05-0110938.11394891945
2025-06-0110952.848722986248
2025-07-0111100.196463654225
2025-08-0111100.196463654225
2025-09-0111119.84282907662
2025-10-0111237.721021611002
2025-11-0110461.689587426326
2025-12-0162878.192534381145
2026-01-0151669.94106090374
2026-02-0131738.703339882126
2026-03-0124066.79764243615
2026-04-0147151.27701375246
Annual Return Matrix
YearAnnual Return
20254.982242990654206
2026-0.25011716919231375
Total Factor Risk
6.5905093202409315
VTI.US Exposure
0.02638750781630841
VEA.US Exposure
0.0005588863318490848
VWO.US Exposure
0.003282307677922674
QQQ.US Exposure
0.017402573704416176
VTV.US Exposure
0.0012149082712666365
IJR.US Exposure
-0.00004351171556253939
QUAL.US Exposure
0.0037062533211670236
SHV.US Exposure
0.8817564938364779
TLT.US Exposure
0.00043506439509669986
LQD.US Exposure
0.0025243268035267294
HYG.US Exposure
0.00036901793089134786
GLD.US Exposure
0.000037587642635952825
USO.US Exposure
0.00009654502868844396
VNQ.US Exposure
0.0014944151620618642
BTC-USD.CC Exposure
0.00006800134125456646
CPER.US Exposure
2.8769479207565235e-7
VIX.INDX Exposure
0.0013974131448321221
UUP.US Exposure
0.000341451123934582
TIP.US Exposure
0.038700505055098214
Idiosyncratic Exposure
0.02026996543334213
Value Score
0
Growth Score
50
Profit Score
37.5
Health Score
23.6
Yield Score
0
Moat Score
40

Factor Risk Decomposition

Share of annualised volatility attributable to each macro factor.

Total Est. Vol
659.1%

FundamentalsiCompany financial health metrics: P/E valuation, dividend yield, Piotroski F-Score (9-point profitability signal), Altman Z-Score (bankruptcy risk proxy), and a radar chart across 6 fundamental dimensions. Note: ETFs may show N/A for some metrics.

Fundamental Dimensions

Core Valuation

P/E Ratio (TTM)P/E RatioPrice-to-Earnings ratio — the market price of a stock divided by its earnings per share, a key valuation measure.Click for full definition →189.7x
Dividend YieldDividend YieldAnnual dividend paid per share divided by the current share price — expressed as a percentage income return.Click for full definition →0.00%
Market Cap$232.3M
Piotroski F-ScorePiotroski F-ScoreA 9-point scoring system evaluating a company's financial strength across profitability, leverage, and operating efficiency.Click for full definition →
9-point profitability signal
0.0/ 9
Weak
Altman Z-ScoreAltman Z-ScoreA bankruptcy prediction model that combines 5 financial ratios into a single score indicating financial distress risk.Click for full definition →
Bankruptcy risk proxy
1.18
Distress Zone
Income Simulation

Based on $10,000 initial investment.

Total Income Generated
$0
Avg Yield on Cost
0.00%

Momentum & MacroiPrice momentum indicators relative to key technical levels: distance from 50-Day SMA (intermediate trend), 200-Day SMA (long-term trend), 52-Week High (bullish proximity), and Beta (market sensitivity coefficient).

vs 50-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+35.9%
Above/below 50-day moving average
vs 200-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
+90.0%
Above/below 200-day moving average
vs 52-Week High52-Week HighThe highest price an asset reached in the past 52 weeks — a key reference for momentum and valuation context.Click for full definition →
45.8% from high
Distance from 52-week high
BetaBetaA measure of an asset's sensitivity to broad market movements relative to a benchmark (e.g. S&P 500).Click for full definition →
-3.70
Market sensitivity coefficient

Frequently Asked Questions & Methodology

Is Aimei Health Technology Co., Ltd Ordinary Share a high-risk investment?

Aimei Health Technology Co., Ltd Ordinary Share (AFJK.US) has an annualized volatility of 659.1% and experienced a maximum drawdown of 61.7% over the last 10 years. Its primary macro risk driver is SHV.US.

What is the 10-year return of AFJK.US?

Over the past 10 years, AFJK.US has generated a Compound Annual Growth Rate (CAGR) of 99.4%. It has had a positive return in 50% of the years measured.

Data Methodology & Trust

The risk and return information on this page is pre-calculated mathematically using daily market data spanning a 10-year period. Fundamentals (such as P/E Ratio, Market Cap, and Dividend Yield) represent trailing averages and may not immediately reflect real-time live market fluctuations. Advanced scoring models like the Piotroski F-Score and Altman Z-Score are proxies applied to publicly available trailing-twelve-month financial statements and may not account for recent off-balance-sheet events, qualitative company shifts, or sector-specific capital structures. Macroeconomic factor exposures are estimated via multivariate regression against standard market indices. This data is provided for quantitative insight and backtesting research, and should not be misconstrued as tailored financial advice.

Run a Full Backtest on Aimei Health Technology Co., Ltd Ordinary Share

stresstest.pro lets you simulate DCA vs Lump Sum, Monte Carlo projections, portfolio optimisation, and more — all in seconds.

Start a Free Backtest